These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9421244

  • 1. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF, Pan Z, Jee WS, Lin CH, Liang HH, Chen H, Pun S, Li XJ.
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF, Lin BY, Jee WS, Lin CH, Chen YY, Ke HZ, Li XJ.
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [Abstract] [Full Text] [Related]

  • 3. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
    Tang LY, Jee WS, Ke HZ, Kimmel DB.
    J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
    [Abstract] [Full Text] [Related]

  • 4. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
    Jee WS, Lin BY, Ma YF, Ke HZ.
    J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
    [Abstract] [Full Text] [Related]

  • 5. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats.
    Pan Z, Jee WS, Ma YF, McOsker JE, Li XJ.
    Bone; 1995 Oct; 17(4 Suppl):291S-296S. PubMed ID: 8579931
    [Abstract] [Full Text] [Related]

  • 6. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
    Chen HK, Jee WS, Ma YF, Pan Z, McOsker JE, Li XJ.
    Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
    [Abstract] [Full Text] [Related]

  • 7. Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
    Ma Y, Chen YY, Jee WS, Ke HZ, Ijiri K.
    Bone; 1995 Oct; 17(4 Suppl):267S-272S. PubMed ID: 8579927
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Skeletal effects of constant and terminated use of sodium risedronate in ovariectomized rats.
    Li QN, Liang NC, Huang LF, Wu T, Hu B, Mo LE.
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):160-3. PubMed ID: 10374643
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY, Jee WS, Ma YF, Ke HZ, Kimmel DB, Li XJ.
    Bone; 1994 Mar; 15(5):489-96. PubMed ID: 7980959
    [Abstract] [Full Text] [Related]

  • 12. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC.
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ, Jee WS, Zeng QQ, Li M, Lin BY.
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [Abstract] [Full Text] [Related]

  • 14. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R.
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [Abstract] [Full Text] [Related]

  • 15. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
    Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF.
    J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
    [Abstract] [Full Text] [Related]

  • 16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats.
    Liang HH, Ma YF, Jee WS, Pan Z, Setterberg RB, McOsker JE, Li XJ.
    Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936
    [Abstract] [Full Text] [Related]

  • 19. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.
    Nam SH, Jeong JH, Che X, Lim KE, Nam H, Park JS, Choi JY.
    Bone; 2012 Jan; 50(1):149-55. PubMed ID: 22036912
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.
    Bonnet N, Beaupied H, Vico L, Dolleans E, Laroche N, Courteix D, Benhamou CL.
    J Bone Miner Res; 2007 Apr; 22(4):578-88. PubMed ID: 17243867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.